Hamburg-based industrial holding company Körber AG has issued a cautious outlook for 2026, expecting a deceleration in revenue and sales growth across its Pharma, Supply Chain, and Technologies divisions.

Growth Forecast Revised Downward

Körber AG expects weaker revenue and sales growth for the 2026 fiscal year compared to previous periods.

Strategic Business Areas Affected

The slowdown is expected to impact the group's core business areas: Pharma, Supply Chain, and Technologies.

Regional Economic Impact

As a major employer in Hamburg and Schleswig-Holstein, the company's performance is a key indicator for northern Germany's industrial sector.

Körber AG expects weaker revenue and sales growth for the 2026 fiscal year compared to previous periods. The Hamburg-based management holding company, which operates across several international markets, issued the forecast on March 14, 2026. This outlook reflects a shift in performance expectations for the group's diversified business portfolio. The announcement follows a period where the company had been navigating various market dynamics across its core industrial sectors. management holding structure allows the firm to oversee its three primary business areas while maintaining centralized financial control.

The company maintains a significant global presence with operations divided into the business areas of Pharma, Supply Chain, and Technologies. These divisions provide specialized solutions ranging from pharmaceutical packaging to automated logistics systems and tobacco processing machinery. While the specific percentage of the projected slowdown was not disclosed in initial reports, the guidance indicates a more cautious approach to the 2026 fiscal calendar. The group currently employs more than 12,500 people across more than 100 locations worldwide. Körber AG was founded by Kurt A. Körber and is headquartered in Hamburg, Germany. The company transitioned into a foundation-owned entity, with the Körber Foundation holding 100% of the shares. In recent years, the group has undergone significant restructuring to focus on its three core pillars: Digital, Pharma, and Supply Chain, often acquiring specialized technology firms to bolster its portfolio.

The weaker growth expectations come amid a broader economic environment where industrial and technology sectors are facing shifting demand. Körber AG's performance is often viewed as an indicator for the health of the Supply Chain and pharmaceutical technology markets. The company achieved a turnover of approximately 2.8 billion euros in 2024, serving as a baseline for its recent expansion efforts. Analysts monitor such forecasts to gauge the impact of global trade trends on German-based multinational engineering and technology groups.

Körber AG